key word IF! I'am long on this for several years and would like to see ppsgo to $4-$5 @ share but your pumping is not needed! keep it up and you will be the first long I ever put on iggy. but a long term holder can only take so much! kindly STFU!
The fundamentals are just obvious, whether it happens on Monday or June, 2011 - whatever.
I was excited to see it at 1.25 today, no way in hell I was selling, I didn't buy this to get out at that level.
I don't know what happened today, but I would suggest to iggy me, because I will not "STFU", kindly - wondering about your mental state to be so hostile with a 10% gain today. In either event, I suggest that you do not read my posts. If you would like to silence my speech, continue to vote for Obama, and maybe we can bring fairness doctrine to the bulletin boards too.
Originally bought in at $3.09 back in Jan 07, than added on the dips, in 08 & 09.
Sure would like a "pop" along with the other longs.
This speculative stock has required patience as the share price kept declining.
My personal opinion is that once Ceplene was given approval the share price was unnecessarily low.
Dilution, and lack of funds didn't help either.
Now is the time for some good news.
Why need annual report?
It's simple question and it says NP-1
4% amitriptyline and 2% ketamine cream.
amitriptyline and ketamine are not new drugs. I think I was right. NP-1 using old drugs with new formulation ( likely patented).
As a matter of the fact, I just listened the CEO talk ( June 09, 2009) and noticed that Ceplene is a co-developed drug, EPCT own how much right 50%, 80%?
Slide #22 indicated that eventually market potential could be double with “label Expansion”
From the slides ( results), I think FDA will approve Ceplene. Five IL-2 alone studies provided enough evidence. In another words, there is not much EPCT need to do.
A (IL-2) no efficacy ( proved by five individaul studies), A + B ( Ceplene) showed significant efficacy, therfore, B is a drug!
NP-1 is very important to the long-term value of the company, but they need a partner....And they have a limited amount of bandwidth...
So first - sort out Ceplene partner, then NP-1 - and try to avoid diluting the shareholders with any type of new raise. (Hopefully the NP1 conversations will not take as long as the Ceplene one seems to be taking).